Easy to start, hard to do right
The seductive thing about IV therapy is its apparent simplicity, and that's precisely what lulls owners into underestimating it. Underneath the easy delivery sit several real requirements: it generally involves the practice of medicine (with the supervision and delegation that implies), the sourcing and compounding of the IV preparations must be appropriate and from legitimate channels, standing orders and protocols have their own constraints, and patients need appropriate medical evaluation before treatment. None of that is visible in the "just hang a bag" framing that makes IV therapy look like a casual menu addition. The combination of low apparent difficulty and real underlying complexity is exactly what produces a population of practices operating in a gray zone they assume is fine.
The sourcing and compounding piece
A specific area worth flagging is sourcing and compounding, because it's both a real risk and easy to get wrong. The IV preparations and their ingredients have to be sourced and prepared appropriately, from legitimate channels, in compliance with the requirements that govern compounding. Using improperly sourced or compounded preparations is a genuine exposure — and one that's attracted regulatory attention as the category has grown. An owner adding IV therapy needs to treat the question of where the preparations come from and how they're prepared as central, not incidental, because it's one of the places the gray zone turns into an actual problem.
Standing orders don't make it simple
As with the good-faith exam, standing orders and protocols can be legitimate parts of a compliant IV structure where permitted — but they're often misunderstood as a way to make the requirements disappear, and they aren't. They don't eliminate the need for appropriate medical evaluation, supervision, and proper sourcing underneath them. How standing orders may be used for IV therapy is state-specific and belongs in a structure designed with your medical director and counsel. Treating them as a shortcut around the medical and sourcing requirements is a misunderstanding that creates exposure rather than removing it — the same trap that catches practices on the good-faith exam, applied to IV.
The scrutiny is increasing
The reason this matters now more than it might have a few years ago is that the rapid proliferation of IV and wellness offerings has drawn attention to exactly these questions — sourcing, supervision, medical appropriateness. Practices that treat IV therapy as a casual, high-margin add-on, without examining the compounding, supervision, and evaluation requirements, are the most exposed to that increasing scrutiny. The category's growth, in other words, has made the gray zone more visible, not less, and the casual approach that was common is becoming riskier.
What to do
- Treat IV therapy as the complex regulatory area it is, not the casual add-on it appears to be — it touches medicine, supervision, sourcing, compounding, and evaluation.
- Scrutinize sourcing and compounding — ensure preparations come from legitimate channels and are prepared appropriately, because this is a primary risk area drawing attention.
- Use standing orders correctly, as part of a compliant structure, never as a shortcut around medical evaluation, supervision, and proper sourcing.
- Structure the whole offering with your medical director and counsel before launching, given increasing regulatory scrutiny of the category.
IV therapy can be a legitimate, valuable part of a wellness-crossover practice — but only when it's approached as the genuinely complex regulatory undertaking it is, rather than the easy high-margin add-on it resembles. The very ease that makes it tempting is what leads practices to skip the sourcing, supervision, and evaluation questions that actually govern it, leaving them in a gray zone that's drawing more scrutiny every year. Examine the requirements, get the sourcing right, structure it with counsel, and IV therapy is a sound offering. Hang the bag casually because it looked simple, and you've entered one of the murkier compliance areas in the business without realizing you crossed the line.
